John Maslowski of Fibrocell Science joined us for World Orphan Drug Congress USA 2015 to present ‘Fibrocell Corporate Presentation’ .
Download the presentation now to learn about:
- Advantages of [Fibrocell’s] Approach
- Recessive Dystrophic Epidermolysis Bullosa (RDEB)
- RDEB Gene Therapy Development
…and much more!
Get your copy here!
To find out more about Fibrocell’s development of gene therapy for RDEB , join us at World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.